Results 231 to 240 of about 4,128,106 (288)
Inverse Design of Nanoparticulate Materials
Advanced Materials, EarlyView.Inverse design shifts nanomaterial development from empirical trial‐and‐error to predictive model‐driven strategies. It can rely on knowledge‐based, data‐based, or hybrid process and property functions. This perspective article provides a practical framework for applying inverse design based on instructive examples. It discusses which modeling approach
Nabi Etienne Traoré +5 more
wiley +1 more source
Healthcare Cost Patterns in CDK4/6 Inhibitor-Treated HR+/HER2- Metastatic Breast Cancer. [PDF]
Clin Drug InvestigKashiwa M, Moriwaki K.
europepmc +1 more source
Comparing prescribing and spending across originator, follow-on, and interchangeable biosimilar insulin glargine: Opportunities to improve uptake of biosimilar medications. [PDF]
J Manag Care Spec PharmAbrams LM, Funk K, Farley JF.
europepmc +1 more source
Temporal trends and regional disparities in costs and affordability of non-insulin antidiabetic drugs in China, 2015-2022: a retrospective observational study. [PDF]
BMJ OpenLiu X +7 more
europepmc +1 more source
Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data. [PDF]
J Cancer Res Clin OncolFroitzheim AC +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2015
The Tufts Center for the Study of Drug Development designed the recent study of the costs of new drug research and development to capture only the costs incurred by industry, but typically R&D efforts in the private and public sectors are complements, not substitutes.
DiMasi, Joseph A +2 more
openaire +2 more sources
The Tufts Center for the Study of Drug Development designed the recent study of the costs of new drug research and development to capture only the costs incurred by industry, but typically R&D efforts in the private and public sectors are complements, not substitutes.
DiMasi, Joseph A +2 more
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1976
PATIENT concern over drug prices frequently finds expression in questions asked of their physicians. What responses can be given? It is good to recognize the pervasive role of drugs in the lives of most patients. The total sales of prescription drugs in 1974 was more than $5 billion.
openaire +2 more sources
PATIENT concern over drug prices frequently finds expression in questions asked of their physicians. What responses can be given? It is good to recognize the pervasive role of drugs in the lives of most patients. The total sales of prescription drugs in 1974 was more than $5 billion.
openaire +2 more sources
JAMA, 2012
MANY PATIENTS CONTINUE TO STRUGGLE WITH THE costs of pharmaceutical products. For patients with chronic diseases, pharmaceutical costs are an unremitting expense. Nonadherence related to the cost of pharmaceutical agents is a major public health issue.
openaire +2 more sources
MANY PATIENTS CONTINUE TO STRUGGLE WITH THE costs of pharmaceutical products. For patients with chronic diseases, pharmaceutical costs are an unremitting expense. Nonadherence related to the cost of pharmaceutical agents is a major public health issue.
openaire +2 more sources